[1] Hawkinson JE, et al. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA binding. Eur J Pharmacol. 1997 Jun 25;329(2-3):213-21. PMID:9226415
[2] Kessler M, et al. Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators. Brain Res. 2006 Mar 3;1076(1):25-41. DOI:
10.1016/j.brainres.2005.09.024[3] Rembach A, et al. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS. J Neurosci Res. 2004 Aug 15;77(4):573-82. DOI:
10.1002/jnr.20191[4] JEREMY R. GREENWOOD . 3-Hydroxypyridazine 1-oxides as carboxylate bioisosteres: A new series of subtype-selective AMPA receptor agonists[J]. Neuropharmacology, 2006, 51 1: Pages 52-59. DOI:
10.1016/j.neuropharm.2006.02.013[5] JIN ZHAI Armando L Ying Ying Zhou. Sensitivity, specificity and limitation of in vitro hippocampal slice and neuron-based assays for assessment of drug-induced seizure liability[J]. Toxicology and applied pharmacology, 2021, 430: Article 115725. DOI:
10.1016/j.taap.2021.115725[6] JARI A. LARM Philip M B Nam Sang Cheung. (S)-5-Fluorowillardiine-mediated neurotoxicity in cultured murine cortical neurones occurs via AMPA and kainate receptors[J]. European journal of pharmacology, 1996, 314 1: Pages 249-254. DOI:
10.1016/s0014-2999(96)00633-4